Where the compound carries an acidic group, for example a carboxylic acid group, the present invention also contemplates salts thereof, preferably non-toxicpharmaceutically acceptable salts thereof, such as the sodium, potassium and calcium salts thereof.Suitable pharmaceutically acceptable salts of the antiparkinsonian and neuroleptic agents used in combination with a NK-1 receptor antagonist acc